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Abstract
Background: Acute kidney injury (AKI) is diagnosed based on postoperative serum creatinine change, but AKI models
have not consistently performed well, in part due to the omission of clinically important but practically unmeasurable
variables that affect creatinine. We hypothesized that a latent variable mixture model of postoperative serum creatinine
change would partially account for these unmeasured factors and therefore increase power to identify risk factors of
AKI and improve predictive accuracy.
Methods: We constructed a two-component latent variable mixture model and a linear model using data
from a prospective, 653-subject randomized clinical trial of AKI following cardiac surgery (NCT00791648) and
included established AKI risk factors and covariates known to affect serum creatinine. We compared model
fit, discrimination, power to detect AKI risk factors, and ability to predict AKI between the latent variable
mixture model and the linear model.
Results: The latent variable mixture model demonstrated superior fit (likelihood ratio of 6.68 × 1071) and enhanced
discrimination (permutation test of Spearman’s correlation coefficients, p < 0.001) compared to the linear model. The
latent variable mixture model was 94% (−13 to 1132%) more powerful (median [range]) at identifying risk factors than
the linear model, and demonstrated increased ability to predict change in serum creatinine (relative mean square error
reduction of 6.8%).
Conclusions: A latent variable mixture model better fit a clinical cohort of cardiac surgery patients than a linear model,
thus providing better assessment of the associations between risk factors of AKI and serum creatinine change
and more accurate prediction of AKI. Incorporation of latent variable mixture modeling into AKI research will
allow clinicians and investigators to account for clinically meaningful patient heterogeneity resulting from
unmeasured variables, and therefore provide improved ability to examine risk factors, measure mechanisms
and mediators of kidney injury, and more accurately predict AKI in clinical cohorts.
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Background
The diagnosis of acute kidney injury (AKI) relies
primarily on changes in serum creatinine concentra-
tions (ΔSCr) [1–3]. Changes in serum creatinine,
however, can be insensitive and nonspecific for renal
injury [4, 5] due to unmeasured confounders such as
changes in creatinine production, myocyte injury,
intravenous fluid administration, and renal functional
reserve [6, 7]. Many of these unmeasured confounders,
also known as latent variables [8], represent an important
source of patient heterogeneity with respect to how and if
AKI manifests, but are clinically impractical or impossible
to measure. Failure to account for factors like these
decreases power to identify risk factors for AKI and
hinders accurate prediction of postoperative AKI.
Latent variable mixture modeling improves the ability to
assess the associations between independent variables and
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an outcome by accounting for the effect of a latent variable.
The model uses measured covariates to empirically stratify
a cohort into subpopulations of patients, represented by a
latent variable, which are more homogenous than the total
cohort. These subpopulations are represented by com-
ponent models which can be combined to form a com-
prehensive model to represent the entire cohort [9].
We hypothesized that a latent variable mixture model
would increase power to identify significant risk factors
for AKI and improve accuracy in predicting a patient’s
postoperative ΔSCr compared to a traditional linear
model. To test this hypothesis, we built a traditional
linear model and a two-component latent variable mixture
model to predict ΔSCr in a well-phenotyped clinical trial of
AKI following cardiac surgery and compared the models’
goodness-of-fit, power to identify established AKI risk




After Vanderbilt University Medical Center Institutional
Review Board approval, we collected data from a 653-
subject prospective clinical trial of perioperative statin use
to prevent AKI following cardiac surgery (NCT00791648).
The study was conducted according to the Declaration of
Helsinki. Patients were eligible to participate in the trial if
they were scheduled for elective coronary artery bypass
grafting, valve surgery, or ascending aortic surgery requiring
thoracotomy or sternotomy. Patients receiving preoperative
renal replacement therapy, with liver dysfunction, acute
coronary syndrome, pregnancy, current CYP3A4 inhibitor
use, and a history of kidney transplant or statin intolerance
were ineligible to participate. Six hundred fifty-three
patients provided written informed consent. Thirty-
eight patients were excluded for failing inclusion
criteria or withdrew for personal reasons prior to study
initiation, and one patient that completed the study re-
ceived hemodialysis on postoperative day one and was
excluded from 48-h ΔSCr model development since
this patient’s ΔSCr no longer reflected renal injury or
function. Thus 614 patients were included. No signifi-
cant association between perioperative statin use and
postoperative AKI was demonstrated in the clinical
trial [10].
Modeling AKI
We chose maximum ΔSCr from baseline to postoperative
day 2 to model AKI because serum creatinine is the most
common and best characterized marker of renal injury, a
48-h interval is consistent with current consensus guide-
lines for AKI diagnosis, and a continuous scale rather than
a binomial threshold for AKI preserves the measurement
of AKI severity and provides the best opportunity to
ascertain differences between linear and latent variable
mixture modeling techniques. Baseline serum creatinine
concentration was defined as the most recent preoperative
creatinine measurement and was measured in inpatients
on the morning of surgery and within a week prior to
surgery in outpatients. Postoperative serum creatinine
concentrations were measured at 2:00 am daily through-
out hospitalization.
We selected model covariates a priori based on estab-
lished predictors of post-cardiac surgery AKI and factors
known to affect serum creatinine production or dilution
[6, 9, 11–14]. Including well-established risk factors for
AKI facilitates comparison of each model’s ability to
identify significant AKI risk factors for the prediction of
ΔSCr. Selected covariates were identical for both the
linear model and the latent variable mixture model and
included age, body mass index (BMI), baseline glomeru-
lar filtration rate estimated using the CKD-EPI formula
(eGFR) [15], baseline serum creatinine, age●baseline
serum creatinine interaction term, baseline hematocrit,
presence of diabetes, presence of hypertension, duration
of surgery, baseline pulse pressure, volume of hydroxyethyl
starch administered during surgery, volume of urine output
during surgery, duration of cardiopulmonary bypass,
duration of aortic cross clamp, maximum intraopera-
tive arterial lactate concentration, and average intra-
operative mean blood pressure adjusted for baseline
mean blood pressure. Dataset completion was excel-
lent (100% of all serum creatinine data were complete;
>99% of all covariate data were complete).
Model development
A linear model and a two-component latent variable
mixture model were each fit to the maximum ΔSCr
from baseline over the first 48 postoperative hours.
The latent variable mixture model is composed of two
traditional linear models, known as component models.
Each component model represents a subpopulation of
patients formed by the latent variable. During fitting, the
mixture model agnostically identifies two distinctive sub-
populations based on covariate patterns with respect to
observed 48-h postoperative ΔSCr. Given that there is
uncertainty regarding individual patient subpopulation
membership (i.e., subpopulation membership is determined
by each patient’s unknown latent variable status, 0 or 1), a
probability of being in each subpopulation is initially
randomly assigned to each patient and then refined
during the iterative model fitting process until conver-
gence criteria are met. Therefore, at the conclusion of
model fitting, a patient whose covariate pattern is very
consistent with subpopulation 1, for example, may be
assigned a 90% probability of subpopulation 1 membership
and a 10% probability of subpopulation 2 membership. In
this way, each patient’s data may contribute to both
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component models, improving overall model fit. Each com-
ponent model represents a data-identified patient subpopu-
lation. If two distinct subpopulations are not identified
during the fitting process, the first component model would
become identical to the traditional linear model and the
coefficients for all the covariates of the second component
model would be assigned a value of zero. After completion
of model fitting, we developed a support vector machine
algorithm to predict patient subpopulation allocation prob-
abilities based on covariate patterns but independent of
observed ΔSCr. This enables prediction of ΔSCr using the
latent variable mixture model and allows us to compare
ΔSCr prediction between latent variable mixture and linear
models.
Statistical analyses
Patient characteristics were summarized with the 50th
(10th, 90th) percentiles for continuous variables and per-
centages for categorical variables. To evaluate the latent
variable mixture model relative to the linear model, we
compared model: 1) goodness-of-fit, 2) average power to
identify established risk factors for AKI, 3) discrimin-
ation (ability to rank subjects in order of predicted
ΔSCr), and 4) accuracy to predict maximum 48-h post-
operative ΔSCr.
Goodness-of-fit was assessed with calibration plots
and r2 calculations of predicted ΔSCr versus observed
ΔSCr for the latent variable mixture and linear models.
To account for the increased flexibility of the latent
variable mixture model with respect to differential model
fit, Bayesian Information Criteria (BIC) values were calcu-
lated for each model and compared using a relative likeli-
hood calculation.
The ability to identify AKI risk factors was assessed
using a post hoc calculation of each model’s power to
identify established risk factors as significant. For this
calculation, 5000 new datasets were generated from our
original dataset using standard parametric bootstrapping
techniques, and both the latent variable mixture model
and the linear model were refit in each new dataset. This
produced a set of new risk factor coefficients and associated
p-values for each model. Using these sets of new model
coefficients, individual risk factor identification power
comparisons between the two models were performed,
taking our original fitted model coefficients as the
power calculations’ alternative hypotheses. A sign test
was used to determine the significance of the power
comparison between the two models. Additionally,
quantile-quantile (Q-Q) plots were used to assess the
normalcy of each model’s errors in order to compare
each model’s covariate coefficient accuracy.
Model discrimination was evaluated with a permuta-
tion test of each model’s Spearman’s correlation coeffi-
cients between predicted and observed ΔSCr.
To evaluate prediction of maximum 48-h postopera-
tive ΔSCr, we compared the average of the square of the
difference between the predicted and true ΔSCr (i.e.,
mean squared error relative difference [(predicted ΔSCr
– true ΔSCr)2]) [16].
Models were bootstrapped with 200 replicates to assess
for over-fitting and provide internal validation. Statistical
analyses were performed in R (version 3.2.0, R Foun-
dation, http://www.r-project.org) and included pROC
and flexmix packages.
Results
Subject characteristics and AKI
Six hundred fourteen patients comprised the study co-
hort. The cohort was primarily Caucasian, and one third
of patients were female (Table 1). Half of the patients
received coronary artery bypass surgery, two-thirds valve
replacement or repair, and three quarters of surgeries were
performed with the use of cardiopulmonary bypass. One
hundred thirty five patients (22.1%) developed KDIGO
AKI. One hundred and nineteen of these patients met the
0.3 mg/dL increase within 48-h criterion, 72 the 50%
increase within 7-days criterion, and 60 both. Twenty-six
patients (4.2% of the total cohort) developed KDIGO stage
II or III AKI, 5 of whom required postoperative renal
replacement therapy.
The median serum creatinine and eGFR at baseline
were 1.01 mg/dl (10th, 90th percentile: 0.74, 1.60) and
73 ml/min/1.73 m2 (38, 97). The median maximum
ΔSCr within 48 h of surgery was 0.07 (−0.13, 0.52) for
the total cohort, 0.50 mg/dl (0.27, 1.04) in patients that
developed KDIGO AKI, and 0.03 (−0.15, 0.20) in patients
that did not develop AKI.
Latent variable mixture model subpopulation
assignments
The two-component latent variable mixture model identi-
fied two distinct subpopulations of patients indicating the
existence of a latent variable. At the completion of model
fitting, 13% of patients had >50% probability of being in
subpopulation 1, and 87% of patients had <50% probability
of being in subpopulation 1 (i.e., 87% of patients had >50%
probability of being in subpopulation 2 (Fig. 1)). If patients
with a >50% probability of being in subpopulation 1 are
assigned to subpopulation 1 and patients with >50% prob-
ability of being in subpopulation 2 are assigned to subpopu-
lation 2, then in general subpopulation 1 tended to be
older, with a greater prevalence of hypertension, diabetes,
and congestive heart failure, and a lower baseline eGFR
(Additional file 1: Table S1).
Model fit
The latent variable mixture model demonstrated superior
goodness-of-fit throughout the range of predicted ΔSCr
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(Fig. 2), resulting in a BIC value of 140 for the latent vari-
able mixture model compared to 349 for the linear model.
These BIC values represent a 6.66 × 1071 times increased
likelihood of the latent variable mixture model providing
superior fit compared to the linear model.
AKI risk factor identification and estimation accuracy
The latent variable mixture model identified a significant
association between 14 of the 16 established AKI risk
factors included as covariates and maximum 48-h ΔSCr,
while the linear model demonstrated a significant associ-
ation between 6 of the 16 established AKI risk factors and
maximum 48-h ΔSCr (Table 2). Post hoc relative power
calculations showed that the latent variable mixture model
had greater power to identify established risk factors as
significant for 15 of the 16 covariates considered compared
to the linear model (sign test, p < 0.001). The latent variable
mixture model exhibited 94% (−13 to 1132%) more power
(median [range]) to identify established risk factors as
having a statistically significant association with 48-h ΔSCr
as the linear model.
A Q-Q plot revealed that the latent variable mixture
model deviated less from the line of best fit than the linear
model (Fig. 3), demonstrating that the latent variable mix-
ture model better fulfilled the linear regression requirement
of normally distributed errors. This signifies that the latent
variable mixture model has an improved ability to accur-
ately assess associations between patient characteristics and
postoperative ΔSCr compared to the linear model.
Model discrimination and prediction of 48-h
postoperative ΔSCr
The latent variable mixture model demonstrated superior
discrimination for predicted ΔSCr compared to the linear
Table 1 Cohort characteristics
Characteristic All subjects (n = 615)
Age, years 67 (50, 81)
Female 188 (30.6%)
African American 26 (4.2%)
Body mass index, kg/m2 27.7 (22.5, 36.9)
Medical history
Hypertension 544 (88.5%)
Congestive heart failure 243 (39.5%)
Left ventricular ejection fraction, % 60 (35, 60)
Myocardial infarction 110 (17.9%)
Prior cardiac surgery 110 (17.9%)
Diabetes 202 (32.8%)
Current smoking 88 (14.3%)
Chronic obstructive pulmonary disease 64 (10.4%)
Peripheral vascular disease 170 (27.6%)
Preoperative medication use
Statin 416 (67.6%)
ACE inhibitor 192 (31.2%)
Baseline laboratory data
Creatinine, mg/dl 1.01 (0.74, 1.60)
eGFR, ml/min/1.73 m2 72.8 (38.5 96.7)
Hematocrit, % 34 (25, 43)
Perioperative atorvastatin treatment assignment 308 (50%)
Procedure characteristics
CABG surgery 301 (48.9%)
Valve surgery 397 (64.6%)
Cardiopulmonary bypass use 435 (70.7%)
Cardiopulmonary bypass time, min 110.0 (0, 211.6)
Aortic cross clamp use 291 (47.3%)
Aortic cross clamp time, min 0 (0, 139.6)
Intraoperative fluids
Intravenous crystalloid, mL 1600 (1000, 3000)
Intravenous hydroxyethyl starch, mL 0 (0, 0)a
Urine output, mL 430 (175, 946)
Arterial lactate, maximum intraoperative, mmol/L 1.7 (0.9, 3.8)
Length of surgery, hours 5.1 (3.6, 7.8)
aOnly 59 of 615 patients received intravenous hydroxyethyl starch during
surgery accounting for the low 10th, 50th, and 90th percentile values. BP
blood pressure, ACE angiotensin converting enzyme, eGFR estimated glomerular
filtration rate using CKD-Epi formula, CABG coronary artery bypass grafting
Binary characteristics are reported as n (%) and continuous characteristics as
median (10th percentile, 90th percentile)
Fig. 1 Histogram of patients’ probabilities of being a member of
subpopulation 1 verses subpopulation 2, determined by a latent
variable. Subpopulation 1 represents patients in whom AKI risk
factors more strongly correlate with 48-h postoperative change in
serum creatinine concentration, and subpopulation 2 less strongly, at
completion of mixture model fit. The black bars represent patients with
less than 50% probability of being a member of subpopulation 1 (>50%
probability of being in subpopulation 2), and the white bars
represent patients with greater than 50% probability of being a member
of subpopulation 1 (<50% probability of being in subpopulation 2)
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Fig. 2 Calibration plots of the linear and latent variable mixture models’ predicted maximum change in serum creatinine concentration (ΔSCr)
from baseline to 48-h after surgery versus the observed maximum ΔSCr from baseline to 48-h after surgery. The dotted line represents the line of
best fit
Table 2 Associations between established AKI risk factor covariates and maximum 48-h serum creatinine change from baseline
using a linear model and each subpopulation of a two-component latent variable mixture model
Risk factor Linear model Latent variable mixture model
Subpopulation 1 Subpopulation 2
Age (per 10 years) 0.037 (−0.044, 0.118) 0.040 (−0.021, 0.101) 0.042 (0.016, 0.068)**
BMI (per 5 kg/m2) 0.040 (0.013, 0.068)** 0.107 (0.081, 0.132)*** 0.012 (0.005, 0.019)***
History of hypertension 0.005 (−0.046, 0.056) 0.080 (0.002, 0.158)* −0.017 (−0.031, −0.003)*
History of diabetes −0.024 (−0.082, 0.035) −0.123 (−0.177, −0.068)*** −0.007 (−0.021, 0.008)
Baseline pulse pressure (per 10 mmHg) 0.003 (−0.009, 0.015) −0.019 (−0.035, −0.003)* 0.004 (7.2e-5, 0.008)*
Baseline SCr (per mg/dL) 0.203 (−0.309, 0.715) 0.054 (−0.217, 0.326) 0.158 (−0.023, 0.339)
Baseline SCr:age interaction −0.001 (−0.008, 0.007) 0.002 (−0.003, 0.007) −0.001 (−0.003, 0.002)
Baseline eGFR (per 30 mL/min/1.73 m2) 0.081 (−0.012, 0.174) 0.045 (−0.066, 0.156) 0.099 (0.051, 0.147)***
Baseline hematocrit (per %) −0.010 (−0.016, −0.005)*** −0.034 (−0.040, −0.028)*** −0.003 (−0.005, −0.001)***
Cardiopulmonary bypass time (per hour) 0.006 (−0.018, 0.030) −0.072 (−0.108, −0.036)*** 0.012 (2.0e-4, 0.024) **
Aortic cross clamp time (per hour) 0.036 (0.001, 0.072)* 0.156 (0.120, 0.192)*** −0.006 (−0.018, 0.006)
Intraoperative hydroxyethyl starch volume (per L) 0.200 (0.000, 0.400) 0.300 (0.100, 0.500)** 0.000 (−0.056, 0.094)
Intraoperative urine output (per L) −0.100 (−0.200, −0.048)** −0.300 (−0.400, −0.200)*** −0.100 (−0.094, −0.016)***
Mean intraoperative MAP adjusted for baseline
MAP (per 10 mmHg)
0.023 (0.003, 0.042)* 0.064 (0.042, 0.086)*** 0.005 (0.001, 0.009)*
Maximum intraoperative lactate (per mmol/L) 0.004 (−0.021, 0.028) −0.009 (−0.033, 0.016) 0.013 (0.007, 0.019)***
Length of surgery (per hour) 0.034 (0.009, 0.059)** 0.113 (0.086, 0.140)*** 0.027 (0.021, 0.034)***
*p < 0.05, **p < 0.01, ***p < 0.001; BMI body mass index, eGFR estimated glomerular filtration rate using CKD-Epi formula, SCr serum creatinine concentration, MAP
mean arterial blood pressure
For example, an increase of ten years in age is associated with a 0.037 increase in 48-h postoperative change in serum creatinine concentration (ΔSCr) in the linear
model, and a past medical history of hypertension was associated with a 0.080 increased in 48-h ΔSCr in the subpopulation 1 component model. Ninety-
five percent confidence intervals are listed after each covariate coefficient estimate
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model (Permutation test of Spearman’s correlation coeffi-
cients, p < 0.001). The relative mean squared error reduc-
tion for the latent variable mixture model comparative to
the linear model was 6.8%, meaning that the latent vari-
able mixture model predicted 48-h postoperative ΔSCr
6.8% more accurately.
Discussion
In this study of perioperative AKI, a latent variable mixture
model had markedly more power to identify established
risk factors for AKI and improved ability to predict a
patient’s postoperative ΔSCr than a traditional linear model.
These benefits were likely due to superior goodness-of-fit,
improved accuracy of covariate coefficient estimation, and
enhanced discrimination of predicted postoperative ΔSCr.
Latent variable mixture modeling may offer substantial
benefits to the study of AKI, and future studies that seek to
isolate risk factors for AKI, measure mechanisms of AKI,
test therapies for AKI, or seek to predict AKI in clinical
cohorts should consider using this methodology.
The improvement of AKI modeling with the latent vari-
able mixture modeling technique indicates that substantial
heterogeneity exists within the perioperative AKI popula-
tion that is not accounted for by observed covariates, and
that reliance on traditional linear modeling techniques
which inherently assume observed covariates are the only
relevant covariates obscures this heterogeneity. This
unaccounted for patient heterogeneity within the AKI
population may explain why numerous AKI prevention
and intervention trials have failed to demonstrate effi-
cacy despite promising preclinical trials.
While new to studies of AKI, latent variable mixture
modeling is an established statistical methodology to ac-
count for patient heterogeneity in other clinical domains.
It has long been used in psychology and genetics research
[17, 18], and more recently in oncology. For example, the
use of latent variable mixture modeling to model small
cell lung cancer growth dynamics from serum biomarker
data has improved the prediction of treatment outcomes
and decreased reliance on sequential imaging [19]. In
acute lung injury, a latent variable mixture modeling tech-
nique recently identified patient phenotypes associated
with differential treatment effects of high versus low posi-
tive end expiratory pressure where traditional modeling
had failed [20]. Identification of latent variable subpop-
ulations in patients at risk for AKI may also lead to the
identification of subpopulation-specific treatment bene-
fits, enhanced risk stratification, and improved predic-
tion of long-term outcomes.
In the current study, the latent variable mixture model
displayed greater power to identify established risk factors
for AKI. This improvement results in increased power to
identify and characterize novel candidate risk factors, in-
cluding baseline characteristics, intraoperative exposures,
perioperative biomarkers, and patient management tech-
niques that could be modified to reduce AKI. Candidate
factors are easily evaluated using the latent variable mix-
ture model by adding the candidate factor to both compo-
nent models before mixture model fitting. The p-value
associated with the candidate factor’s coefficient for each
component model determines the significance of the can-
didate factor in each patient subpopulation. Using latent
variable mixture modeling to assess candidate factors will
increase discernment of their association with AKI and
benefit the search for other non-latent, modifiable AKI
risk factors, particularly in modestly sized patient cohorts
where power may be low.
Development of the latent variable mixture model does
not itself identify the latent variable or binomial pattern of
variables, but can suggest potential candidates including
renal functional reserve, genetic polymorphisms, clusters
of disease exposure, fluid management strategies, or surgi-
cal treatments. For example, renal functional reserve is a
potentially source of heterogeneity in susceptibility that
leads to variation in the manifestation of AKI across
patients [7, 21–26]. In our study, older age and higher co-
morbidity burden (e.g., diabetes, hypertension) is poten-
tially consistent with a population with less renal reserve
compared to subpopulation 2 in whom traditional risk
modeling performed less well [7, 27, 28]. In the former, a
potential lack of renal reserve might explain the larger
model coefficients associated with established AKI risk
factors such as history of hypertension and diabetes, BMI,
baseline hematocrit, aortic cross clamp duration, and
length of surgery. In contrast, the potential presence of
Fig. 3 Quantile-quantile plot of the linear and latent variable
mixture model’s error distributions. The dotted line represents
the ideal distribution of model errors to ensure accurate risk
factor identification
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renal functional reserve might contribute to smaller, and
frequently statistically insignificant, model coefficients for
established AKI risk factors in subpopulation 2. The latter
subpopulation might represent patients in whom sensitive
AKI biomarkers may better predict the potential long-term
impact of AKI than currently emphasized risk factors.
Irrespective of the identity of the latent variable, our
results indicate that latent variable mixture modeling
can identify subpopulations of patients that may be
used to enrich outcomes in clinical trials, target moni-
toring and interventions, and shed novel insight into
the pathophysiology of AKI.
Strengths of this study include the use of high-quality
unbiased data collected as part of a prospective clinical trial
with little to no missing data. We also retained serum
creatinine as a continuous variable to enhance AKI discrim-
ination and prediction [29, 30]. At the same time we ac-
knowledge potential limitations. We did not evaluate latent
variable mixture models with more than two subpopula-
tions or perform latent class analysis to empirically deter-
mine the number of subpopulations to model. Given the
goal of comparing latent variable mixture modeling to trad-
itional linear modeling techniques, we selected the simplest
latent variable mixture model for this initial assessment.
We observed dramatic results, but increased latent variable
flexibility could further improve AKI modeling. A second
limitation was the small number of patients that developed
moderate or severe AKI (100 or 200% ΔSCr – KDIGO
stage II or III), which limited our power to compare latent
variable mixture modeling to linear modeling techniques
with high precision in patients with moderate or severe
AKI. A majority of patients that develop postoperative AKI,
however, develop mild AKI, and this outcome remains
associated with major short and long-term morbidity
[31–33]. Finally, it should be acknowledged that the
predictive accuracy of the latent variable mixture model
could be reduced in datasets missing model covariate
information. However, due to increased model flexibility,
the latent variable mixture model will always display equal
to or better predictive accuracy compared to a linear
model with the same covariates.
Conclusions
A latent variable mixture model increased power to
identify established AKI risk factors, more accurately
ranked the severity of patients’ 48-h ΔSCr, and more ac-
curately predicted 48-h postoperative ΔSCr compared to a
linear model. Latent variable mixture modeling may im-
prove clinicians’ ability to identify novel risk factors and
advance the understanding of AKI pathophysiology. Em-
ployment of this technique could also advance preopera-
tive AKI risk stratification and provide opportunities to
further phenotype and target higher risk patient subpopula-
tions with specific monitoring, preventative strategies, and
treatments. Latent variable mixture modeling may provide
a powerful technique to advance the study of AKI.
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